Clinical Trial Update: Evaluation of the Safety and the Efficacy of Carfilzomib Combined With Cyclophosphamide and Dexamethasone (CCyd) or Lenalidomide and Dex (CRd) Followed by ASCT or 12 Cycles of Carf Combined With Dex and Len for Patients Eligible for ASCT With Newly Diagnosed Multiple Myeloma. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of carfilzomib-based regimens (CCyd or CRd) followed by autologous stem cell transplant or extended ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Decadron (Dexamethasone)
• Kyprolis (carfilzomib)
• Revlimid (lenalidomide)

Snippet

Sponsor: Mario Boccadoro | Conditions: MULTIPLE MYELOMA (MM) | Phase 2 | Status: COMPLETED